Brand Name(s): Pepcid Oral; Pepcid AC
CAS nº: 76824-35-6
(fa moe' ti deen)

About Famotidine

This new reference site is dedicated exclusively to famotidine.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about famotidine, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total famotidine experience! 

Why is this medication prescribed?

Famotidine is in a class of drugs called histamine receptor antagonists, and works by decreasing the amount of acid the stomach produces.

This medication is used to treat and prevent ulcers in the stomach and intestines. Furthermore, it is also administered to treat conditions in which the stomach produces too much acid and for situations in which acid comes up into the esophagus and causes heartburn, such as gastroesophageal reflux disease (GERD).

It is commonly marketed by Merck under the trade names Pepcidine® and Pepcid®.

See more Product Info

Latest News

Generic Competition for Last Remaining OTC Pepcid

Perrigo secured FDA approval of a generic version of Pepcid Complete, the chewable formulation of...

[more]

Common Reflux Treatment Linked To Life Threatening Bowel Infection In Premature Infants

Researchers in an NIH network have found that premature infants given a common class of...

[more]

FDA Approves Johnson & Johnson·Merck's Prescription Strength PEPCID® AC (famotidine 20 mg) for Over-The-Counter

Maximum Strength PEPCID® AC Provides a Strong and Effective Treatment Option for the Millions...

[more]

Teva Announces Final Approval of Famotidine 20 & 40mg

Jerusalem, Israel - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.